Cancer-related Problem/Condition
Conditions
Brief summary
Nausea and vomiting are two of the side effects associated with the most common antineoplastic chemotherapy treatments. The Medical Taping Concept (MTC) is an economical technique, easy to apply. This is a technique that may help reduce nausea and vomiting after application of chemotherapy in cancer patient.
Detailed description
Nausea and vomiting are two of the side effects associated with the most common antineoplastic chemotherapy treatments. There are some studies that support the use of physical measures such as TENS or acupuncture to lessen these effects. The Medical Taping Concept (MTC) is an economical technique, easy to apply and few side effects. In some manuals on this technique the possibility that it may act to reduce nausea and vomiting described. Sim But after a comprehensive literature search have not found jobs to support these assumptions. With this work, the research team will attempt to obtain evidence on the effects of its application in the areas of influence of the dermatome T7 and T8. For this, two adhesive tapes of this type of bandage is placed on the front and back on a group of patients after receiving chemotherapy session and compared with a control group that will apply this technique outside the dermatome indicated . Both groups will receive antiemetics according to the service routine. If the hypothesis were positive it could extend the application of this simple technique to cancer patients from other centers in order to help reduce nausea and vomiting.
Interventions
DEVICECure Tape™ covering T 7 and T 8 dermatomes
The intervention group will have to apply two strips of special hypoallergenic tape called Cure Tape™ that will have a size of 20 x 5 cm and they will have to be placed on the T7-T8 dermatome area.
DEVICECure Tape™ away from dermatomes T 7 and T 8
The control group will have to apply two strips of special hypoallergenic tape called Cure Tape™ that will have a size of 5 x 4 cm and they will have to be placed near the greater trochanter area.
Sponsors
Hospital Universitario San Juan de Alicante
Universidad Miguel Hernandez de Elche
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Neoadjuvant and adjuvant breast cancer * To have been diagnosed with a severe comorbid disorder * To have received at least the first cycle of emetogenic chemotherapy
Exclusion criteria
* Not suffer nausea or vomiting episodes in the previous cycle of chemotherapy, * To Shower inability to report nausea and / or vomiting.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference between Number of times you have vomited during the first 24 hours after the first chemotherapy session and after the second chemotherapy session | 24 hours after the first chemotherapy session and 24 hours after the second chemotherapy session | 1, 2, 3, 4, 5, ......... |
| Difference between nausea after the first chemotherapy session and after the second chemotherapy session | 24 hours after the first chemotherapy session and 24 hours after the second chemotherapy session | Nausea (Yes / No) |
| Difference between Intensity of nausea in the experience of the participant after the first chemotherapy session and after the second chemotherapy sessionintervention and pre-intervention | 24 hours after the first chemotherapy session and 24 hours after the second chemotherapy session | numerical scale from 0 to 10 (0 = No / 10 = maximum) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference between Quality of life post-intervention and pre-intervention | 24 hours after chemotherapy and 4 days after chemotherapy | EQ-5D™ is a standardised instrument for use as a measure of health outcome |
Countries
Spain
Contacts
Primary ContactMaria Isabel Tomás-Rodríguez, Doctor
Outcome results
None listed